Equelle
TINA.org investigated the marketing for Equelle, a menopause supplement brand owned and marketed by Pharmavite, and found that it is deceptively advertised as “clinically shown” to provide menopause relief and treat a variety of menopausal symptoms, including hot flashes, night sweats, insomnia, vaginal discomfort, anxiety, depression, and muscle and joint pain.
To see TINA.org’s evidence, click here.
Timeline
2024
October 1
TINA.org files a complaint with the FTC and FDA regarding unsubstantiated and unapproved claims in marketing for Equelle and urging the agencies to take enforcement action. TINA.org sends a copy of the complaint letter to Pharmavite.
2023
April
The FTC sends a Notice of Penalty Offenses Concerning Substantiation of Product Claims to Pharmavite.
Evidence
Featured
The Menopause Deception Epidemic
How the supplement industry is taking advantage of women and what TINA.org is doing to fight it.
The Latest
Most Deceptive Ads of 2024
Here were some of the worst ads TINA.org investigated this year.
TINA.org Files FTC & FDA Complaints Against Menopause Supplement Brands
An investigation into the menopause supplement industry by consumer advocacy organization truthinadvertising.org (TINA.org) has revealed a hotbed of deceptive advertising. The ad watchdog has amassed nearly 2,000 examples of problematic health…
Consumer Alert: Menopause Supplements
Proceed with caution when it comes to menopause marketing.